3/25
08:30 am
atxi
Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
Medium
Report
Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
3/18
04:20 pm
atxi
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Low
Report
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
3/18
04:05 pm
atxi
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
Low
Report
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
3/15
08:15 am
atxi
Avenue Therapeutics Receives Positive Listing Determination from Nasdaq
Medium
Report
Avenue Therapeutics Receives Positive Listing Determination from Nasdaq
3/11
08:00 am
atxi
Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting
Medium
Report
Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting
2/22
08:35 am
atxi
Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy [Yahoo! Finance]
Low
Report
Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy [Yahoo! Finance]
2/22
08:30 am
atxi
Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy
High
Report
Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy
2/2
02:55 pm
atxi
Lindsay Rosenwald's Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries [Yahoo! Finance]
Low
Report
Lindsay Rosenwald's Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries [Yahoo! Finance]
1/11
08:00 am
atxi
Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference
Low
Report
Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference
1/5
09:24 am
atxi
Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds [Yahoo! Finance]
High
Report
Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds [Yahoo! Finance]
1/5
09:15 am
atxi
Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds
High
Report
Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds
1/4
08:44 am
atxi
Avenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol [Yahoo! Finance]
Medium
Report
Avenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol [Yahoo! Finance]
1/4
08:30 am
atxi
Avenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol
High
Report
Avenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol
1/2
08:38 am
atxi
Avenue Therapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease) [Yahoo! Finance]
Medium
Report
Avenue Therapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease) [Yahoo! Finance]
1/2
08:30 am
atxi
Avenue Therapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
Low
Report
Avenue Therapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)